Pancreatitis and GLP-1 Medicines: Symptoms, Evidence and Safety

Pancreatitis is inflammation of the pancreas, the organ that makes digestive enzymes and insulin. It can be serious. According to the NIH's digestive-disease institute (NIDDK), gallstones are the most common cause of acute pancreatitis, and heavy alcohol use is another; some medicines and genetic conditions can also play a role.

US prescribing information for GLP-1 and related medicines—including Ozempic, Wegovy, Mounjaro and Zepbound—includes an acute pancreatitis warning. That warning deserves attention. It does not mean every stomach ache during treatment is pancreatitis.

Which symptoms call for urgent assessment?

The labels describe the key pattern as persistent or severe abdominal pain, sometimes spreading to the back, with or without nausea or vomiting. NIDDK also lists fever, a fast heartbeat, a swollen or tender belly, shortness of breath and yellowing of the skin or eyes as reasons to get care right away.

If you notice this kind of pain, seek urgent medical care. Don't wait for a routine appointment or try to decide at home whether it's "just the medicine." The labels tell prescribers to stop the medicine if pancreatitis is suspected, so it's a decision for the clinician assessing you—who may use an exam, blood tests and imaging to find the cause. Our guide to severe stomach pain on GLP-1 covers other warning signs too.

What does the research say about risk?

The honest answer: pancreatitis is rare in the trials, and the numbers are hard to pin down.

• Labels: The US labels say acute pancreatitis, including rare fatal forms, has been seen in people taking GLP-1 receptor agonists. In Zepbound's weight-management trials, adjudicated acute pancreatitis occurred in 0.2% of people on tirzepatide and 0.2% on placebo. Wegovy's label reports confirmed cases in 4 people on semaglutide versus 1 on placebo in its weight trials.
• Meta-analysis of randomized trials: A 2025 Gastroenterology review pooled 55 placebo-controlled trials (about 106,000 participants). It found GLP-1 medicines increased gallstones and probably reflux, but probably had little or no effect on pancreatitis compared with placebo.
• Real-world reports: Reports after a medicine reaches the market can flag possible problems, but they can't show how often something happens or prove the medicine caused it.

Because gallstones are the leading cause of pancreatitis, and GLP-1 medicines are linked to a higher rate of gallbladder problems, gallbladder symptoms are worth taking seriously too.

Who should share their history with the prescriber?

The patient information for these medicines asks you to tell your clinician if you have or have had problems with your pancreas. It's also worth mentioning gallstones, heavy alcohol use, very high triglycerides or other relevant conditions, plus all medicines and supplements you take. That helps your prescriber make an individual decision; a general article can't tell you whether a medicine is right for you.

What to do if you are worried

Ask your prescriber which symptoms need urgent action for your specific medicine, and where to go outside office hours. If severe, persistent pain starts, getting assessed comes first. A symptom log can be helpful afterwards, but it should never delay care.

The main message: know the warning, know what urgent pain looks like, and let a clinical assessment—not online certainty—decide the cause.